Trial intelligence / Profile preview

DP-b99 in Acute Ischemic Hemispheric Stroke

NCT00190047Phase 2Completed

Sponsor
D-Pharm
Start
Feb 2005
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of DP-b99 in ischemic stroke, sponsored by D-Pharm. Started Feb 2005; status: completed.

02

Drugs

DP-b99
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT00190047.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00190047.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call